Healthcare company Medline said on Tuesday that its respiratory division has received an exclusive distribution agreement from Southmedic with access to the latter's latest breakthrough in advanced oxygen delivery technology in the OxyMask portfolio.
This agreement provides Medline with the non-exclusive access to Southmedic's OxyMask EtCO2 portfolio.
Through the partnership, the customers across the continuum of care gets greater access to high quality products that are designed with fit, function and compliance in mind.
Southmedic's OxyMask's revolutionary open design provides a cost effective solution for patients whose oxygen requirements may vary throughout their hospital stay.
Additionally, OxyMask's reduces the risk and dangers associated with aspiration or rebreathing CO2. It reduces the feelings of claustrophobia and allows unrestricted communication for patients. The possibility of skin breakdown is reduced and aids in the compliance of prescribed oxygen therapy by reducing interruptions, concluded the companies.
Kromek collaborates on next-gen CT detector technology
Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention
European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV
Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring
Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus
Seres Therapeutics provides business updates and reports Q2 2023 financial results